FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 77 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,886,000 | -40.2% | 2,473,026 | -5.8% | 0.00% | -40.0% |
| Q1 2019 | $9,842,000 | +4.5% | 2,624,445 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $9,421,000 | -29.2% | 2,624,445 | +13.0% | 0.01% | -14.3% |
| Q3 2018 | $13,304,000 | +77.6% | 2,321,745 | +55.2% | 0.01% | +75.0% |
| Q2 2018 | $7,493,000 | -2.3% | 1,495,545 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,672,000 | -14.6% | 1,495,545 | +0.1% | 0.00% | 0.0% |
| Q4 2017 | $8,983,000 | +8.2% | 1,494,645 | -0.1% | 0.00% | 0.0% |
| Q3 2017 | $8,303,000 | +19.3% | 1,495,970 | -0.2% | 0.00% | +33.3% |
| Q2 2017 | $6,957,000 | -6.2% | 1,499,370 | +0.0% | 0.00% | -25.0% |
| Q1 2017 | $7,420,000 | -56.6% | 1,498,870 | -2.6% | 0.00% | -55.6% |
| Q4 2016 | $17,086,000 | +19.9% | 1,539,270 | 0.0% | 0.01% | +28.6% |
| Q3 2016 | $14,254,000 | +46.0% | 1,539,270 | +0.1% | 0.01% | +40.0% |
| Q2 2016 | $9,766,000 | -2.7% | 1,537,970 | -0.1% | 0.01% | 0.0% |
| Q1 2016 | $10,035,000 | -26.1% | 1,539,060 | -8.1% | 0.01% | -28.6% |
| Q4 2015 | $13,585,000 | +9.5% | 1,675,060 | -1.0% | 0.01% | +16.7% |
| Q3 2015 | $12,404,000 | -22.6% | 1,692,200 | +8.3% | 0.01% | -14.3% |
| Q2 2015 | $16,019,000 | – | 1,562,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |